SCHEMBL3336562

SCHEMBL3336562

O=C(NCc1ccccc1)c1ccc2[nH]c(=O)c3cccn3c2c1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 7/20 0.69
IMPDH2 P12268 1/20 0.52
RXFP1 Q9HBX9 2/20 0.51
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
ALDH1A1 P00352 3/20 0.50
ADORA3 P0DMS8 1/20 0.49
ADORA1 P30542 1/20 0.49
GAA P10253 2/20 0.48
KDM4E B2RXH2 1/20 0.48
GLA P06280 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
BRPF1 P55201 1/20 0.48
TSHR P16473 1/20 0.46
TP53 P04637 2/20 0.45
MAPT P10636 2/20 0.45
HDAC2 Q92769 1/20 0.45
HDAC8 Q9BY41 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45
MAPK3 P27361 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3084927 0.81 PARP1 (1.00) PARP1RXFP1ALDH1A1BRPF1TP53
SCHEMBL3335735 0.80 PARP1 (0.59) PARP1TP53
SCHEMBL3077319 0.80 PARP1 (0.81) PARP1RXFP1MEN1KMT2ATP53
SCHEMBL3344731 0.78 PARP1 (0.59) PARP1MEN1KMT2AALDH1A1KDM4E
SCHEMBL3083967 0.78 PARP1 (0.64) PARP1KMT2AALDH1A1GAAKDM4E
SCHEMBL3338082 0.77 PARP1 (0.72) PARP1ALDH1A1GAAKDM4EHDAC2
SCHEMBL3338380 0.76 PARP1 (0.54) PARP1KMT2AALDH1A1GAAKDM4E
SCHEMBL31500071 0.76 PARP1 (0.54) PARP1KMT2AALDH1A1GAAKDM4E
SCHEMBL891491 0.75 ALDH1A1 (0.56) IMPDH2RXFP1MEN1KMT2AALDH1A1
SCHEMBL3073097 0.74 PARP1 (0.67) PARP1RXFP1ALDH1A1GAAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100152180-A1 4-oxo-4,5-dihydropyrrolo[1,2-A)quinoxaline derivatives as inhibitors of poly(ADP-ribose) polymerase (PARP) ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2010-06-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100152180-A1 4-oxo-4,5-dihydropyrrolo[1,2-A)quinoxaline derivatives as inhibitors of poly(ADP-ribose) polymerase (PARP) PARP1, PARP2, PARP4 PARP1 1/4885IMPDH2 1900/4885RXFP1 1383/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.